Novozymes (OTC:NVZMY) reported quarterly earnings of $1.27 per share which beat the analyst consensus estimate of $0.60 by 111.67 percent. This is a 44.32 percent increase over earnings of $0.88 per share from the same period last year. The company reported quarterly sales of $2.608 billion which beat the analyst consensus estimate of $1.250 billion by 108.64 percent. This is a 9.76 percent increase over sales of $2.376 billion the same period last year.